Conference Proceedings

CANOPY phase III program: Three studies evaluating canakinumab in patients with non-small cell lung cancer (NSCLC)

L Paz-Ares, EB Garon, A Ardizzoni, F Barlesi, BC Cho, G de Castro Junior, P De Marchi, E Felip, Y Goto, A Greystoke, S Lu, DW-T Lim, VA Papadimitrakopoulou, M Reck, BJ Solomon, D Spigel, DSW Tan, M Thomas, JC-H Yang, B Johnson

ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2019

Grants

Funding Acknowledgements

Novartis Pharmaceuticals.